Related Experiment Video
Updated: Sep 22, 2025

08:00
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
18.4K
Application of 7T MRS to High-Grade Gliomas
L McCarthy1, G Verma2, G Hangel3,4
1From the Department of Neurosurgery (L.M., C.G.H.), Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, New York lily.mccarthy@icahn.mssm.edu.
AJNR. American Journal of Neuroradiology
|May 26, 2022
Summary
7 Tesla Magnetic Resonance Spectroscopy (7T MRS) offers enhanced visualization of high-grade gliomas, improving metabolite detection and potentially guiding new neuro-oncologic treatments. Further technical advancements are needed for wider clinical adoption.
Area of Science:
- Neuro-oncology
- Medical Imaging
- Metabolomics
Background:
- High-grade gliomas exhibit aberrant metabolic activity.
- Magnetic Resonance Spectroscopy (MRS) detects metabolites in gliomas.
- 7 Tesla (7T) MRS shows potential for increased sensitivity compared to lower field strengths.
Purpose of the Study:
- To summarize the literature on 7T MRS for high-grade gliomas.
- To identify metabolic information, optimal sequences, and applications of 7T MRS.
- To highlight areas for improvement and future research in 7T MRS.
Main Methods:
- Literature search on PubMed using keywords: "high-grade glioma," "malignant glioma," "glioblastoma," "anaplastic astrocytoma," "7T," "MR spectroscopy," and "MR spectroscopic imaging."
- Review of studies focusing on the utility of 7T MRS in visualizing and characterizing high-grade gliomas.
Main Results:
- 7T MRS provides higher signal-to-noise ratio (SNR), improved spatial resolution, and better separation of overlapping resonances.
- It enables more sensitive quantification of D-2-hydroxyglutarate and precise measurement of glutamate, glutamine, and glycine.
- 7T MRS may enhance characterization of tumor infiltration and treatment response, with reduced Cramér-Rao lower bound values.
Conclusions:
- 7T MRS advances the understanding of high-grade glioma metabolism by improving metabolite detection.
- Technical improvements are necessary for broader clinical use, including larger sample sizes and reduced acquisition times.
- 7T MRS has the potential to identify novel therapeutic targets and expand neuro-oncologic applications.

